DCF Advisers’s Zai Lab ZLAB Stock Holding History

DCF Advisers’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.19M	Sell	63,500 -34,000	-35%	-$630K	0.32%	52
2025 Q4	$1.72M	Buy	97,500 +5,500	+6%	+$129K	0.46%	52
2025 Q3	$3.12M	Buy	92,000 +1,000	+1%	+$34.4K	1%	31
2025 Q2	$3.18M	Buy	91,000 +1,000	+1%	+$32.9K	1.47%	24
2025 Q1	$3.25M	Buy	90,000 +25,250	+39%	+$777K	1.56%	22
2024 Q4	$1.7M	Buy	64,750 +22,500	+53%	+$625K	0.82%	38
2024 Q3	$1.02M	Buy	42,250 +11,800	+39%	+$223K	0.41%	53
2024 Q2	$528K	Buy	+30,450	New	+$535K	0.27%	67

Other funds holding ZLAB

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

DCF Advisers's ZLAB Position: Q1 2026 in Review

DCF Advisers reduced its Zai Lab (ZLAB) stake by 35% in Q1 2026, selling an estimated $630K and leaving 63,500 shares worth $1.19M. The position accounts for 0.32% of the portfolio, ranked #52.

DCF Advisers first reported a position in ZLAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.25M in Q1 2025. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

DCF Advisers held 63,500 shares of Zai Lab worth $1.19M as of Q1 2026.
DCF Advisers sold 34,000 Zai Lab shares in Q1 2026, an estimated $630K.
Zai Lab made up 0.32% of DCF Advisers's portfolio in Q1 2026, its #52 holding.
DCF Advisers first reported a position in Zai Lab in Q2 2024 and has held it in 8 quarters since.
DCF Advisers's Zai Lab position peaked at $3.25M in Q1 2025.
99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.